Active substance
Coal tar
- Health Canada 2
- UK MHRA 2
- NHS prices 5
- WHO EML 1
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| COAL-TAR SHAMPOO | 02538954 | 0.5 % / W/W | SHAMPOO · TOPICAL | SEAFORD PHARMACEUTICALS INC |
| DERM OIL | 02448963 | 10 % / W/V | SOLUTION · TOPICAL | DERMTEK PHARMA INC |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| PSORIDERM CREAM | PL 00173/5000R | DIOMED DEVELOPMENTS LIMITED | P |
| PSORIDERM SCALP LOTION SHAMPOO | PL 00173/5001R | DIOMED DEVELOPMENTS LIMITED | P |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Coal tar 2.5% scalp lotion | £5.18 | 250 ml | 1 Oct 2026 |
| NHS Drug Tariff | Coal tar 4% shampoo | £7.57 | 150 ml | 1 Oct 2026 |
| NHS Drug Tariff | Coal tar 6% cream | £11.10 | 225 ml | 1 Oct 2026 |
| NHS Drug Tariff | Coal tar solution 5% cutaneous emulsion | £10.14 | 100 ml | 1 Oct 2026 |
| NHS Drug Tariff | Coal tar solution 5% cutaneous emulsion | £20.30 | 250 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 13.4. Dermatological medicines > Medicines affecting skin differentiation and proliferation · core
Psoriasis of unspecified type
Local > Topical > Solution: 5%
Combinations containing Coal tar
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.